IL6 and metabolic syndrome: Future studies including this parameter and other relevant biomarkers linked to the metabolic syndrome, e.g. interleukin (IL)-6, tumour necrosis factor (TNF)-α and C-reactive protein (using high-sensitivity assays), should assist in further interpretation of the data obtained.